Figure 1
From: Does safety make a difference in selecting the right TNF antagonist?
Infusion reactions by dosage of infliximab as reported in the ATTRACT study. All patients received concomitant methotrexate. ATTRACT, Anti-Tumor Necrosis Factor Trial in Rheumatoid Arthritis with Concomitant Therapy [12–14].